 HIGH POINT, N.C., April 12, 2021 GLOBE NEWSWIRE -- vTv Therapeutics Inc. Nasdaq: VTVT a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for type 1 diabetes and inflammatory diseases, today announced that results from the JDRF-supported SimpliciT-1 Study will be presented at A Scientific Symposium: In celebration of the 100th anniversary of the University of Torontos discovery of insulin Insulin100 held virtually, April 15 16, 2021. 